share_log

Lifeist Announces Common Share Consolidation

Lifeist Announces Common Share Consolidation

Lifeist宣佈合併普通股
GlobeNewswire ·  05/01 06:00

TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that its Board of Directors has approved the consolidation of its common shares on the basis of a ratio of one (1) post-consolidation common share for every twenty (20) pre-consolidation common shares, subject to TSX-V approval (the "Consolidation"). Neither the Company's name nor its trading symbol will change in connection with the Consolidation. The Consolidation was approved by the Company's shareholders at the annual and special meeting held on March 14, 2024 (the "AGSM"). Further details about the Consolidation can be found in the Company's management information circular dated February 2, 2024 (the "Circular") distributed to shareholders in connection with the AGSM, a copy of which is available on SEDAR+ at .

多倫多,2024 年 4 月 30 日(GLOBE NEWSWIRE)— Lifeist Wellness Inc.(“Lifeist” 或 “公司”)(多倫多證券交易所股票代碼:LFST)(法蘭克福股票代碼:M5B)(OTCMKTS:LFSWF)今天宣佈,其董事會已批准合併其普通股按合併前每二十(20)股普通股中每持一(1)股合併後普通股的比率計算,但須經多倫多證券交易所批准(“合併”)。公司的名稱和交易代碼都不會因合併而發生變化。合併已在2024年3月14日舉行的年度和特別會議(“AGSM”)上獲得公司股東的批准。有關合並的更多詳細信息可以在公司於2024年2月2日向股東分發的與AGSM相關的管理信息通告(“通函”)中找到,該通告的副本可在SEDAR+上查閱,網址爲。

As stated in the Circular for the AGSM, management is of the view that the current share structure of the Company makes it difficult or impossible for the Company to attract business opportunities or any additional equity financing that may be required by the Company. Management is of the opinion that the Consolidation will increase its flexibility and present additional opportunities with respect to potential business transactions, including any equity financing.

正如AGSM通告中所述,管理層認爲,公司目前的股權結構使公司難以或不可能吸引商機或公司可能需要的任何額外股權融資。管理層認爲,合併將提高其靈活性,併爲包括任何股權融資在內的潛在商業交易提供更多機會。

Currently, there are 594,087,243 common shares issued and outstanding, and after the Consolidation is effective there will be approximately 29,704,362 common shares issued and outstanding. No fractional shares will be issued as a result of the Consolidation. Instead, any fractional share interest of 0.5 or higher arising from the Consolidation will be rounded up to one whole share, and any fractional share interest of less than 0.5 will be cancelled without further compensation.

目前,共有594,087,243股普通股已發行和流通,合併生效後,將發行和流通約29,704,362股普通股。合併後不會發行任何零碎股票。取而代之的是,因合併而產生的任何0.5或以上的部分股權將四捨五入爲整股,任何小於0.5的部分股權將被取消,恕不另行補償。

The Company will issue a future news release announcing the effective date of the Consolidation and its new CUSIP and ISIN numbers.

該公司將發佈未來的新聞稿,宣佈合併的生效日期及其新的CUSIP和ISIN編號。

Registered shareholders of the Company that hold their shares in certificated form will receive a letter of transmittal from the Company's transfer agent, Computershare Investor Services Inc., with instructions for exchanging their pre-consolidation shares for post-consolidation shares. Shareholders who hold their shares in DRS or through a broker or other intermediary will not need to complete a letter of transmittal.

以認證形式持有股份的公司註冊股東將收到公司過戶代理人Computershare Investor Services Inc.的送文函,其中包含將其合併前的股份兌換成合並後股份的指示。持有DRS股份或通過經紀人或其他中介機構持有股份的股東無需填寫送文函。

Lifeist also reports, further to its June 30, 2023 news release, as required by the approval of the TSXV in connection with the Consulting Agreement dated June 30, 2023 and as amended on February 1, 2024, entered into by the Company with Singular Narrative Management Ltd. ("Singular") for the provision of strategic business consulting, product development, and brand marketing services to the Company as well as other services that do not include investor relations or promotional activities, that it has issued an aggregate of 8,000,000 common shares and 2,400,000 common share purchase warrants to acquire up to 2,400,000 common shares as payment to Singular of the monthly fee of $20,000 for services provided in the month of January and the monthly fee of $40,000 for services provided in the months of February and March 2024, calculated in accordance with the amended Consulting Agreement. The common shares were issued at deemed prices per share of $0.01. The warrants have an exercise price of $0.05 per share and expire 5 years from their respective date of issuance.

繼2023年6月30日發佈新聞稿後,Lifeist還報告說,根據多倫多證券交易所批准的2023年6月30日諮詢協議的要求,公司與Singular Narrative Management Ltd.(“Singular”)簽訂了經2024年2月1日修訂的諮詢協議,向公司提供戰略業務諮詢、產品開發和品牌營銷服務以及不包括投資者關係或促銷活動的其他服務,它總共發行了800萬股普通股和240萬股普通股購買權證,可收購最多240萬股普通股,作爲向Singular支付的月費爲20,000美元,用於支付根據修訂後的諮詢協議計算的2024年2月和3月提供的服務的月費爲40,000美元。普通股以每股0.01美元的認定價格發行。認股權證的行使價爲每股0.05美元,自各自的發行之日起5年內到期。

About Lifeist Wellness Inc.

關於 Lifeist Wellness

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories.

Lifeist處於疫情後健康革命的最前沿,利用科學和技術的進步來建立突破性公司,改變人類健康。投資組合業務部門包括:開發和銷售細胞健康創新產品的生物科學和消費者健康公司Mikra;CannMart,該公司經營B2B批發分銷業務,促進向加拿大省政府控制委員會銷售休閒大麻,包括生產高利潤大麻2.0產品的BHO提取設施CannMart Labs;以及澳大利亞最大的蒸發器和配件在線零售商之一澳大利亞Vapes。

Information on Lifeist and its businesses can be accessed through the links below:

有關Lifeist及其業務的信息可以通過以下鏈接訪問:

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com

聯繫人:
Meni Morim
首席執行官
Lifeist健康公司
Ph:647-362-0390
電子郵件:ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任,也未以任何方式批准或不批准本新聞稿的內容。

Forward Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新聞稿包含適用證券法所指的 “前瞻性信息”。此處包含的所有非歷史性陳述均包含前瞻性信息。前瞻性信息可以通過單詞或短語來識別,例如 “可能”、“期望”、“可能”、“應該”、“將”、“計劃”、“預期”、“打算”、“潛在”、“提議”、“估計”、“相信” 或這些術語的否定詞、表達方式和語法變體,或某些事件或條件 “可能” 或 “將” 發生的陳述。

The forward-looking information contained herein, including, without limitation, statements related to the Consolidation are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, the Consolidation can be effective shortly and may enable the Company to achieve some of the benefits described herein as a result of the Consolidation, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the inability of the Company to obtain TSXV approval for the Consolidation, in a timely manner, if at all, the Consolidation failing to achieve its intended benefits, the Company's failure to develop its businesses as anticipated and risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR+ profile at . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

此處包含的前瞻性信息,包括但不限於與合併相關的陳述,是截至本新聞稿發佈之日作出的,其依據是管理層在發表此類聲明時認爲合理的假設,包括但不限於合併可能很快生效,可能使公司能夠通過整合實現本文所述的部分好處,以及其他被認爲適合具體情況的考慮因素。儘管根據管理層目前獲得的信息,我們認爲這些假設是合理的,但無法保證此類預期會被證明是正確的。就其性質而言,前瞻性信息受固有的風險和不確定性的影響,這些風險和不確定性可能是一般性的,也可能是具體的,這些風險和不確定性可能導致預期、預測、預測、預測或結論不準確,假設可能不正確,目標、戰略目標和優先事項無法實現。各種因素,包括已知和未知的風險,其中許多是我們無法控制的,可能導致實際業績與本新聞稿中的前瞻性信息存在重大差異。這些因素包括但不限於:公司無法及時獲得多倫多證券交易所對合並的批准(如果有的話)、合併未能實現預期收益、公司未能按預期發展業務以及與公司執行業務戰略的能力及其可帶來的收益相關的風險。其他風險因素還可以在公司SEDAR+簡介下提交的公司當前的MD&A中找到,網址爲。提醒讀者不要過分依賴前瞻性信息。除非適用法律要求,否則公司沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。本新聞稿中包含的前瞻性陳述受本警示聲明的明確限制。

Source: Lifeist Wellness Inc.

資料來源:Lifeist Wellness


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論